- Filed
- Mar 31, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Mar 23, 2026 | 63.58M sh |
| Shares Diluted | FY 2025 · Dec 31, 2025 | 47.93M sh |
| Shares Diluted | FY 2025 · Dec 31, 2024 | 18.66M sh |
| Capex | FY 2025 · Dec 31, 2025 | $76.08K |
| Capex | FY 2025 · Dec 31, 2024 | $57.91K |
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | −$27.63M |
| Operating Cash Flow | FY 2025 · Dec 31, 2024 | −$14.73M |
| Cash And Equivalents | FY 2025 · Dec 31, 2025 | $3.62M |
| Cash And Equivalents | FY 2025 · Dec 31, 2024 | $12.66M |
| Stockholders Equity | FY 2025 · Dec 31, 2025 | $20.93M |
| Stockholders Equity | FY 2025 · Dec 31, 2024 | $14.59M |
| Stockholders Equity | FY 2025 · Dec 31, 2023 | −$1.56M |
| Current Liabilities | FY 2025 · Dec 31, 2025 | $5.92M |
| Current Liabilities | FY 2025 · Dec 31, 2024 | $5.33M |
| Total Liabilities | FY 2025 · Dec 31, 2025 | $6.42M |
| Total Liabilities | FY 2025 · Dec 31, 2024 | $5.37M |
| Current Assets | FY 2025 · Dec 31, 2025 | $4.62M |
| Current Assets | FY 2025 · Dec 31, 2024 | $19.61M |
| Total Assets | FY 2025 · Dec 31, 2025 | $27.35M |
| Total Assets | FY 2025 · Dec 31, 2024 | $19.97M |
| Eps Diluted | FY 2025 · Dec 31, 2025 | −$0.63 |
| Eps Diluted | FY 2025 · Dec 31, 2024 | −$1.21 |
| Eps Basic | FY 2025 · Dec 31, 2025 | −$0.63 |
| Eps Basic | FY 2025 · Dec 31, 2024 | −$1.21 |
| Sga Expense | FY 2025 · Dec 31, 2025 | $7.58M |
| Sga Expense restated | FY 2025 · Dec 31, 2024 | $3.87M |
| Rd Expense | FY 2025 · Dec 31, 2025 | $20.53M |
| Rd Expense | FY 2025 · Dec 31, 2024 | $13.34M |
| Net Income | FY 2025 · Dec 31, 2025 | −$30.05M |
| Net Income | FY 2025 · Dec 31, 2024 | −$21.68M |
| Revenue | FY 2025 · Dec 31, 2025 | $0 |
| Revenue | FY 2025 · Dec 31, 2024 | $0 |